Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study

oleh: Danielle R. Davari, Irene Orlow, Peter A. Kanetsky, Li Luo, Klaus J. Busam, Ajay Sharma, Anne Kricker, Anne E. Cust, Hoda Anton-Culver, Stephen B. Gruber, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Terence Dwyer, David C. Gibbs, David W. Ollila, Colin B. Begg, Marianne Berwick, Nancy E. Thomas

Format: Article
Diterbitkan: MDPI AG 2021-11-01

Deskripsi

Genome-wide association studies (GWAS) and candidate pathway studies have identified low-penetrant genetic variants associated with cutaneous melanoma. We investigated the association of melanoma-risk variants with primary melanoma tumor prognostic characteristics and melanoma-specific survival. The Genes, Environment, and Melanoma Study enrolled 3285 European origin participants with incident invasive primary melanoma. For each of 47 melanoma-risk single nucleotide polymorphisms (SNPs), we used linear and logistic regression modeling to estimate, respectively, the per allele mean changes in log of Breslow thickness and odds ratios for presence of ulceration, mitoses, and tumor-infiltrating lymphocytes (TILs). We also used Cox proportional hazards regression modeling to estimate the per allele hazard ratios for melanoma-specific survival. Passing the false discovery threshold (<i>p</i> = 0.0026) were associations of <i>IRF4</i> rs12203592 and <i>CCND1</i> rs1485993 with log of Breslow thickness, and association of <i>TERT</i> rs2242652 with presence of mitoses. <i>IRF4</i> rs12203592 also had nominal associations (<i>p</i> < 0.05) with presence of mitoses and melanoma-specific survival, as well as a borderline association (<i>p</i> = 0.07) with ulceration. <i>CCND1</i> rs1485993 also had a borderline association with presence of mitoses (<i>p</i> = 0.06). <i>MX2</i> rs45430 had nominal associations with log of Breslow thickness, presence of mitoses, and melanoma-specific survival. Our study indicates that further research investigating the associations of these genetic variants with underlying biologic pathways related to tumor progression is warranted.